Drug Database
Back to search

Poland· PL-100102631

Miansegen

A mianserin product containing mianserini hydrochloridum, registered in Poland by Viatris Ltd. The same ATC class is registered in 15 of our 19 countries.

ATC N06AX03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedMiansegenATCN06AX03REGISTER NO.PL-100102631PACKS LISTED7CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about mianserini hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Mianserin is registered in 15 of 19 countries.

Countries holding a registration under ATC N06AX03 (mianserin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search mianserin products by name

Mianserin · ATC N06AX03

15 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of mianserin costs, country by country.

Normalised to the WHO defined daily dose (60 mg), the median price runs from $0.32 in France to $1.15 in Switzerland — a ×3.6 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Mianserin · price per daily dose (60 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.15
  • IT Italy$0.68
  • FR France$0.32
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Mianserini hydrochloridum
Manufacturer
Viatris Ltd
Country
Poland (PL)
ATC code
N06AX03
ATC class
Mianserin
Defined daily dose
60 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 7

1 priced
  • gtin
    05909990883912
  • gtin
    05909990764242
    30 szt.
    PLN 26.9
  • gtin
    05909990983926
  • gtin
    05909990764259
  • gtin
    05909990830770
  • gtin
    05909990830787
  • gtin
    05909990883929

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

19 interactions on record for mianserin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check mianserin against other medicinesHow interaction checks work

Mianserin · interactions on record

19 records

19 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Mianserin in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mianserin products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Mianserin Viatris, Tolvon
  • Belgium · Lerivon
  • Cyprus · Mianserin Remedica
  • Czechia · Lerivon
  • Germany · Mianserin, Mianserin Neuraxpharm
  • Denmark · Mianserin Orifarm, Mianserin Viatris
  • Spain · Lantanon
  • Finland · Tolvon
  • France · Mianserine Arrow, Mianserine Biogaran
  • United Kingdom (Northern Ireland) · Mianserin Generics Uk
  • Hungary · Miagen
  • Iceland · Mianserin Mylan
  • Italy · Lantanon
  • Luxembourg · Lerivon
  • Malta · Mianserin Remedica
  • Netherlands · Tolvon
  • Norway · Mianserin Viatris
  • Portugal · Tolvon
  • Sweden · Mianserin Viatris
  • Slovakia · Lerivon

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/becde7c2-94ef-4865-b982-9579097a38ff
GET /v1/drugs/becde7c2-94ef-4865-b982-9579097a38ff?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "30 mg",
  "packaging": "05909990883912 ¦ Rp ¦ Skasowane ¦ 17724\n28 tabl.\n05909990983926 ¦ Rp ¦ Skasowane ¦ 20807\n20 tabl.\n05909990764242 ¦ Rp ¦ 56337\n30 tabl.\n05909990764259 ¦ Rp ¦ Skasowane ¦ 56338\n30 tabl. (2 x 15)\n05909990830770 ¦ Rp ¦ 63064\n60 tabl.\n05909990830787 ¦ Rp ¦ 63065\n90 tabl.\n05909990883929 ¦ Rp ¦ 127843\n20 tabl.",
  "substance": "Mianserini hydrochloridum 30 mg",
  "common_name": "Mianserini hydrochloridum",
  "pl_product_id": "100102631",
  "pozwolenie_nr": "08839",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about mianserin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console